Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
ConditionRetinoblastoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorFrench Africa Pediatric Oncology Group
About this trial
As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.
Eligibility criteria
Qualifiers
Unilateral intraocular Retinoblastoma (RB)
Unilateral extraocular intraorbital (RB)
Bilateral intraocular (RB)
bilateral intraocular (RB) on one side and extraocular but intraorbital on the other side.
Disqualifiers
Externalized tumor mass
massive extension to optic nerve up to optical channeltumor
intracranial extension leptomeninges
cerebral parenchyma
Trial design
Treatments tested in this trial
- OBSERVATIONAL
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov